WO2006104510A3 - Water-soluble compound - Google Patents

Water-soluble compound Download PDF

Info

Publication number
WO2006104510A3
WO2006104510A3 PCT/US2005/028181 US2005028181W WO2006104510A3 WO 2006104510 A3 WO2006104510 A3 WO 2006104510A3 US 2005028181 W US2005028181 W US 2005028181W WO 2006104510 A3 WO2006104510 A3 WO 2006104510A3
Authority
WO
WIPO (PCT)
Prior art keywords
water
compound
soluble compound
mitotic
magnetic
Prior art date
Application number
PCT/US2005/028181
Other languages
French (fr)
Other versions
WO2006104510A2 (en
Inventor
Jack A Tuszynski
Howard J Greenwald
Stephen H Curry
Kendrick Goss
Original Assignee
Technology Innovations Llc
Jack A Tuszynski
Howard J Greenwald
Stephen H Curry
Kendrick Goss
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/923,615 external-priority patent/US20070149496A1/en
Application filed by Technology Innovations Llc, Jack A Tuszynski, Howard J Greenwald, Stephen H Curry, Kendrick Goss filed Critical Technology Innovations Llc
Publication of WO2006104510A2 publication Critical patent/WO2006104510A2/en
Publication of WO2006104510A3 publication Critical patent/WO2006104510A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Abstract

A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000 x 10-6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200 x 10-6.
PCT/US2005/028181 2004-08-20 2005-08-09 Water-soluble compound WO2006104510A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/923,615 US20070149496A1 (en) 2003-10-31 2004-08-20 Water-soluble compound
US10/923,615 2004-08-20

Publications (2)

Publication Number Publication Date
WO2006104510A2 WO2006104510A2 (en) 2006-10-05
WO2006104510A3 true WO2006104510A3 (en) 2009-04-09

Family

ID=37053826

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/028181 WO2006104510A2 (en) 2004-08-20 2005-08-09 Water-soluble compound

Country Status (1)

Country Link
WO (1) WO2006104510A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111323280A (en) * 2020-03-26 2020-06-23 重庆市食品药品检验检测研究院 Pretreatment method for determination of silicon element in fluorine-containing injection packaged by medicinal glass
CN117607311B (en) * 2024-01-19 2024-03-29 地奥集团成都药业股份有限公司 Detection method of benazepril hydrochloride enantiomer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498945B1 (en) * 1997-05-19 2002-12-24 Amersham Health As Sonodynamic therapy using an ultrasound sensitizer compound
US7060705B2 (en) * 2001-11-07 2006-06-13 Merck & Co., Inc. Mitotic kinesin inhibitors

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498945B1 (en) * 1997-05-19 2002-12-24 Amersham Health As Sonodynamic therapy using an ultrasound sensitizer compound
US7060705B2 (en) * 2001-11-07 2006-06-13 Merck & Co., Inc. Mitotic kinesin inhibitors

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GEORGOULIAS, VASSILIS.: "Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer.", CURRENT MEDICINIAL CHEMISTRY, vol. 9, 2002, pages 869 - 877 *
KUNSTFELD, R ET AL., THE JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 120, no. 3, March 2003 (2003-03-01), pages 476 - 482 *
LINDER, JR. ET AL.: "Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes.", CIRCULATION, vol. 102, no. 22, 28 November 2000 (2000-11-28), pages 2745 - 2750 *

Also Published As

Publication number Publication date
WO2006104510A2 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
TWI371498B (en) Fe-based amorphous alloy ribbon
EP1035172A3 (en) Azomethine compound and oily magenta ink
DE60118037D1 (en) ORGANIC PHOTOCHROME COMPOSITION WITH IMPROVED KINETIC PROPERTIES
WO2006104510A3 (en) Water-soluble compound
WO2003085040A3 (en) Nano-particle preparation and applications
AU2001275059A1 (en) Epoxy based reinforcing patches with improved adhesion to oily metal surfaces
AU2002246240A1 (en) Dispersants
DE602004025986D1 (en) UBB LOOP ANTENNA
EP0992564A4 (en) Organic electroluminescent device
CA2285118A1 (en) Foundry exothermic assembly
AU6157800A (en) Binding agents modified with nanoparticles, for coatings, and use thereof
AU2001232043A1 (en) Dendrimers
ATE550405T1 (en) FLUORESCENT MARKING AGENTS AND FLUORESCENT MARKING METHODS
AU3373600A (en) Polymer surface coating made by coalescing polymer particulate with a coalescingagent
DE60009772D1 (en) Quenched, thin tape made of a magnetic alloy based on rare earth / iron / boron
DE60022159D1 (en) Transmitter with closed feedback for modulation
MXPA01001333A (en) Lift dolly with pedal latch mechanism.
EP1564758A3 (en) Rare earth sintered magnet, and method for improving mechanical strength and corrosion resistance thereof
EP1189113A3 (en) Electrophotosensitive material
DE50206488D1 (en) VEHICLE WITH A LOCKABLE DOOR OPENING
EP1191005A3 (en) Gas-generating compositions
EP1205681A3 (en) Hub for carbon clutch plates
EP1323718A3 (en) Haptens, immunogens and antibodies to oxycodone and its metabolites
JP2002234892A5 (en)
UA84052C2 (en) Coumarin derivative and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase